Summit Securities Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.7K Buy
410
+172
+72% +$25.5K 0.01% 484
2026
Q1
$22.2K Buy
+238
New +$21.1K ﹤0.01% 505
2024
Q4
Sell
-66
Closed -$7K 606
2024
Q3
$7K Buy
+66
New +$7.72K ﹤0.01% 403
2024
Q1
Sell
-718
Closed -$93K 417
2023
Q4
$93K Buy
+718
New +$99K 0.01% 343
2014
Q4
Sell
-375
Closed -$3K 590
2014
Q3
$3K Buy
+375
New +$2.82K ﹤0.01% 590

Other funds holding ACLS

Summit Securities Group's ACLS Position: Q2 2026 in Review

Summit Securities Group increased its Axcelis (ACLS) stake by 72% in Q2 2026, buying an estimated $25.5K and bringing the position to 410 shares worth $77.7K. The position accounts for 0.01% of the portfolio, ranked #484.

Summit Securities Group first reported a position in ACLS in Q3 2014 and has held it in 5 quarters since. The position peaked at $93K in Q4 2023. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Summit Securities Group held 410 shares of Axcelis worth $77.7K as of Q2 2026.
  • Summit Securities Group bought 172 Axcelis shares in Q2 2026, an estimated $25.5K.
  • Axcelis made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #484 holding.
  • Summit Securities Group first reported a position in Axcelis in Q3 2014 and has held it in 5 quarters since.
  • Summit Securities Group's Axcelis position peaked at $93K in Q4 2023.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.